A study co-led by UCLA and Baylor College of Medicine evaluated whether wearable TENS devices may help alleviate pain and ...
Patients can minimize winter slip-and-fall injuries through proactive measures like wearing proper footwear and clearing ...
Luna, provider of in-home, outpatient physical therapy (PT), has partnered with Duke Health to broaden access to PT services ...
Summary: Out-of-pocket costs for branded drugs for neurological diseases, particularly for multiple sclerosis (MS), have ...
New research from Edith Cowan University highlights how brain interference in muscle activation contributes to challenges in rehabilitation for people with hip osteoarthritis, emphasizing the ...
A research team at Case Western Reserve University is pioneering a novel approach to multiple sclerosis (MS) treatment by targeting toxic astrocytes, with the goal of protecting and regenerating nerve ...
Nervonik, a medical device startup, successfully completed its first-in-human clinical study for a novel peripheral nerve stimulation (PNS) device aimed at treating chronic pain, demonstrating safety, ...
Cerevance has initiated the Phase 3 ARISE trial to evaluate solengepras, a non-dopaminergic therapy targeting specific brain circuits, as a potential adjunctive treatment for Parkinson’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback